Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Carcinoma, Renal Cell 13Melanoma 7Neoplasms 3Sarcoma, Kaposi 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Lymphoma 2Leukemia 2Kidney Neoplasms 2Hematologic Neoplasms 2HIV Infections 2Brain Neoplasms 2Acquired Immunodeficiency Syndrome 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Thrombocythemia, Essential 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Osteosarcoma 1Myeloproliferative Disorders 1Mycosis Fungoides 1Margins of Excision 1Lymphoma, T-Cell 1Lymphoma, Follicular 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Hairy Cell 1Hodgkin Disease 1

Interventions

Cyclophosphamide 49fludarabine phosphate 42Busulfan 41Peripheral Blood Stem Cell Transplantation 40Cyclosporine 30Tacrolimus 29Antilymphocyte Serum 28Mycophenolic Acid 26Radiotherapy 25Methotrexate 25Imatinib Mesylate 21Methylprednisolone 20Whole-Body Irradiation 19Dasatinib 17Filgrastim 16Melphalan 15Interferon-alpha 15Cord Blood Stem Cell Transplantation 15sargramostim 12nilotinib 12Cytarabine 12Etoposide 11Cyclosporins 7Alemtuzumab 7merphos 6asciminib 6Sirolimus 6Homoharringtonine 6thymoglobulin 4ponatinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Myeloid, Chronic-Phase × Interferon alpha-2 × Clear all
NCT00003239 2012-07-30

Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

M.D. Anderson Cancer Center

Phase 2 Completed
90 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡